“The FDA’s recent decision to approve a generic version of the abortion pill is a life-threatening mistake,” Eagle Forum’s President Kris Ullman stated. “Because of this action, even more babies will be killed and more women seriously harmed. At a time when the dangers of Mifepristone are at last being studied, to move forward and approve its generic equivalent is madness.”
 
On September 30th, the United States Food and Drug Administration (FDA) approved a generic version of the abortion pill Mifepristone despite continuous calls from pro-life advocates for a serious study of the drug.  Pro-life advocates have urged the Administration to conduct a thorough review of the Biden administration’s faulty approval process, the underreported harms to women, and the lax standards regarding the administration of the abortion pill.
 
In August, 22 state Attorneys General sent a letter to Health and Human Services Secretary Robert F. Kennedy, Jr., urging him to reinstate safety protocols for the drug because of the high rates of complications to women from taking Mifepristone. The Ethics and Public Policy Center found that 1 in 10 women have experienced life-threatening symptoms after using the abortion pill, including hemorrhaging and infection. The Biden Administration removed important safety protocols, such as requiring in-person visits both before and after women are given Mifepristone, because of the life-threatening complications that can occur.
 
According to an HHS spokesman, the Secretary must approve an application if it demonstrates that the generic drug is identical to the brand-name drug, and generic applications aren’t required to provide evidence proving safety or effectiveness. “The FDA has already begun its study on the safety of Mifepristone,” Ullman stated. “It seems incredibly reckless to approve the generic when so many questions remain around the original drug.”
 
“It is time that HHS takes the dangers to women through the abortion pill seriously,” continued Ullman. “Eagle Forum calls on HHS to reinstate all safety protocols on Mifepristone and ultimately revoke the FDA approvals of this drug and its generic versions. Women’s and babies’ lives are on the line.”